This webinar has now concluded

Allogeneic Cell Therapy Webinar

Allogeneic cell therapies space are transforming the cell therapy landscape by offering a viable and scalable alternative to autologous treatments. This webinar delve into the differences between allogeneic and autologous therapies and highlighted the unique advantages and recent advancements driving the evolution of allogeneic solutions.

In our latest webinar, in collaboration with Hanson Wade Intelligence, we cut through the noise to take a 360-degree view of the allogeneic research and commercial landscape.

Allogeneic Cell Therapy Innovations

We discussed the potential of allogeneic therapies across oncology and non-oncology and featured insights on leading developers, therapeutic classes, and current targets. Additionally, our industry experts provided an overview of clinical market trends, regulatory landscapes, and strategic considerations to help stakeholders make informed decisions. Watch the recording now.

Our Experts

Rachel East

 

House Speaker

Senior Research Analyst

Beacon

Ahmed Tajmohamed

 

House Speaker

Market Analyst

Hanson Wade Intelligence

Thomas Vickers

 

Moderator

Account Manager

Beacon

You May Also Be Interested In…

What is Beacon?

Beacon is a world leading data analysis tool for preclinical and clinical trial information. With unrivalled granularity of search function, data quality, and exhaustiveness, Beacon provides timely information and gives you confidence to progress your targeted drug therapies to patients.

Learn more about how our clinical trials and drug database solutions can be tailored to your research requirements

Find out more

Menu
Search Icon
Close Icon
Search